RAPT Therapeutics, Inc. (RAPT) Shares Issued (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Shares Issued for 5 consecutive years, with $8.2 million as the latest value for Q4 2024.
- Quarterly Shares Issued rose 1687.99% to $8.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2024, up 519.0% year-over-year, with the annual reading at $9.0 million for FY2024, 519.0% up from the prior year.
- Shares Issued hit $8.2 million in Q4 2024 for RAPT Therapeutics, up from $701000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $134.8 million in Q2 2021 to a low of -$133.3 million in Q3 2021.
- Historically, Shares Issued has averaged $4.9 million across 5 years, with a median of $413000.0 in 2021.
- Biggest five-year swings in Shares Issued: crashed 54091.87% in 2021 and later skyrocketed 18059.81% in 2022.
- Year by year, Shares Issued stood at $3.8 million in 2020, then tumbled by 89.13% to $413000.0 in 2021, then surged by 18059.81% to $75.0 million in 2022, then crashed by 99.39% to $458000.0 in 2023, then surged by 1687.99% to $8.2 million in 2024.
- Business Quant data shows Shares Issued for RAPT at $8.2 million in Q4 2024, $701000.0 in Q2 2024, and $67000.0 in Q1 2024.